Skip to main content
. 2002 Jul;184(13):3699–3703. doi: 10.1128/JB.184.13.3699-3703.2002

FIG. 2.

FIG. 2.

Role of the AcrAB-TolC efflux pump and its activating pathways in the development of resistance of icdA mutants to nalidixic acid. •, icdA RH1854; ▪, wild-type (RH1854); ▾, ΔacrAB (RBH1855); ○, icdA ΔacrAB (icdA RBH1855). Other strains are derivatives of icdA RBH1854. Additional mutations are marA (▴), rob (▿), soxS (□), mar sox (⋄), and rob sox (▵).